Financial Snapshot

Revenue
$104.7M
TTM
Gross Margin
3.0%
TTM
Net Earnings
-$81.87M
TTM
Current Assets
Q1 2024
Current Liabilities
Q1 2024
Current Ratio
111.38%
Q1 2024
Total Assets
Q1 2024
Total Liabilities
Q1 2024
Book Value
$5.168M
Q1 2024
Cash
Q1 2024
P/E
-0.7649
Nov 29, 2024 EST
Free Cash Flow
-$21.31M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Revenue $6.545M $98.15M $89.49M $71.48M $65.06M $63.94M $61.50M $53.00M
YoY Change -93.33% 9.68% 25.19% 9.87% 1.75% 3.97% 16.04%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Revenue $6.545M $98.15M $89.49M $71.48M $65.06M $63.94M $61.50M $53.00M
Cost Of Revenue $6.536M $93.10M $85.78M $53.31M $34.64M $31.69M $32.14M $27.18M
Gross Profit $9.141K $5.054M $3.711M $18.18M $30.42M $32.25M $29.35M $25.82M
Gross Profit Margin 0.14% 5.15% 4.15% 25.43% 46.75% 50.44% 47.72% 48.72%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Selling, General & Admin $2.823M $64.18M $49.60M $14.99M $12.66M $8.240M $7.250M $6.960M
YoY Change -95.6% 29.39% 230.91% 18.39% 53.66% 13.66% 4.17%
% of Gross Profit 30882.23% 1269.78% 1336.49% 82.47% 41.62% 25.55% 24.7% 26.96%
Research & Development $1.397M $1.684M $1.660M $2.359M $2.160M $1.860M $1.660M
YoY Change -17.04% 1.45% -29.63% 9.21% 16.13% 12.05%
% of Gross Profit 27.64% 45.38% 9.13% 7.75% 6.7% 6.34% 6.43%
Depreciation & Amortization $1.126K $1.615M $1.553M $849.5K $674.2K $700.0K $140.0K $150.0K
YoY Change -99.93% 3.98% 82.87% 25.99% -3.68% 400.0% -6.67%
% of Gross Profit 12.32% 31.96% 41.85% 4.67% 2.22% 2.17% 0.48% 0.58%
Operating Expenses -$4.631M $73.45M $61.60M $16.65M $15.02M $10.40M $9.110M $8.610M
YoY Change -106.3% 19.24% 269.96% 10.85% 44.43% 14.16% 5.81%
Operating Profit -$4.622M -$68.39M -$57.89M $1.526M $15.40M $21.85M $20.24M $17.21M
YoY Change -93.24% 18.15% -3894.01% -90.09% -29.53% 7.95% 17.61%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Interest Expense $39.17K $72.30K $85.99K $111.8K $98.09K -$40.00K -$110.0K -$480.0K
YoY Change -45.83% -15.92% -23.08% 13.98% -345.22% -63.64% -77.08%
% of Operating Profit 7.33% 0.64% -0.18% -0.54% -2.79%
Other Income/Expense, Net $831.5K -$335.2K $139.5K $125.6K $133.4K $100.0K $240.0K $300.0K
YoY Change -348.08% -340.28% 11.04% -5.83% 33.41% -58.33% -20.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Pretax Income -$3.790M -$68.73M -$57.75M $1.651M $15.53M $21.91M $20.36M $17.02M
YoY Change -94.49% 19.02% -3596.94% -89.37% -29.11% 7.61% 19.62%
Income Tax $0.00 $3.457M -$3.726M $959.4K $2.844M $3.180M $2.870M $2.500M
% Of Pretax Income 58.1% 18.31% 14.51% 14.1% 14.69%
Net Earnings -$6.980M -$71.74M -$49.19M $786.4K $12.69M $18.72M $17.49M $14.52M
YoY Change -90.27% 45.84% -6355.51% -93.8% -32.22% 7.03% 20.45%
Net Earnings / Revenue -106.64% -73.09% -54.97% 1.1% 19.5% 29.28% 28.44% 27.4%
Basic Earnings Per Share -$12.63 -$1.22 $0.03 $0.53
Diluted Earnings Per Share -$2.13 -$12.63 -$1.22 $0.03 $0.53 $813.9K $699.6K $580.8K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Cash & Short-Term Investments $944.2K $3.400M $19.73M $36.56M $33.65M $14.80M $8.880M $4.270M
YoY Change -72.23% -82.77% -46.02% 8.64% 127.36% 66.67% 107.96%
Cash & Equivalents $944.2K $3.400M $19.73M $36.56M $33.65M $14.80M $8.880M $4.270M
Short-Term Investments
Other Short-Term Assets $1.896M $4.400M $7.909M $22.19M $4.260M $6.050M $30.00K $80.00K
YoY Change -56.91% -44.37% -64.36% 420.89% -29.59% 20066.67% -62.5%
Inventory $300.0K $1.390M $1.785M $2.030M $1.970M $2.270M $3.730M
Prepaid Expenses
Receivables $11.36K $1.700M $27.45M $34.56M $30.04M $32.01M $32.56M $23.41M
Other Receivables $0.00 $0.00 $89.33K $0.00 $0.00 $10.00K $20.00K $730.0K
Total Short-Term Assets $2.852M $9.800M $56.57M $95.10M $69.98M $54.84M $43.76M $32.22M
YoY Change -70.9% -82.68% -40.51% 35.89% 27.61% 25.32% 35.82%
Property, Plant & Equipment $12.60K $8.500M $11.25M $10.51M $7.900M $7.810M $8.790M $8.520M
YoY Change -99.85% -24.42% 6.97% 33.09% 1.15% -11.15% 3.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $2.200M $9.424M $5.138M $6.500M $2.260M
YoY Change -100.0% -76.65% 83.41% -20.95% 187.61%
Total Long-Term Assets $4.877M $26.50M $40.86M $17.65M $15.12M $10.84M $9.640M $9.310M
YoY Change -81.6% -35.14% 131.52% 16.71% 39.48% 12.45% 3.54%
Total Assets $7.729M $36.30M $97.43M $112.7M $85.10M $65.68M $53.40M $41.53M
YoY Change
Accounts Payable $2.560M $18.60M $12.16M $8.841M $1.550M $1.660M $5.400M $6.060M
YoY Change -86.23% 53.01% 37.49% 470.4% -6.63% -69.26% -10.89%
Accrued Expenses $2.190K -$53.04K $110.0K $510.0K $360.0K
YoY Change -104.13% -148.22% 41.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.200M $2.268M $2.237M $2.880M $1.040M $1.490M $1.850M
YoY Change -100.0% -3.01% 1.4% -22.33% 176.92% -30.2% -19.46%
Long-Term Debt Due $0.00 $290.0K
YoY Change -100.0%
Total Short-Term Liabilities $2.560M $21.00M $17.93M $15.11M $5.510M $4.760M $8.840M $18.01M
YoY Change -87.81% 17.12% 18.69% 174.19% 15.76% -46.15% -50.92%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $210.0K
YoY Change -100.0%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $210.0K
YoY Change -100.0%
Total Liabilities $2.148M $21.60M $19.30M $18.00M $5.510M $4.760M $8.840M $18.21M
YoY Change -90.05% 11.92% 7.23% 226.66% 15.76% -46.15% -51.46%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Basic Shares Outstanding 4.733M shares 5.678M shares 40.49M shares 26.16M shares 23.84M shares
Diluted Shares Outstanding 4.733M shares 5.678M shares 40.49M shares 40.49M shares 23.84M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $62.623 Million

About Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company is headquartered in Nanping, Fujian and currently employs 7 full-time employees. The company went IPO on 2019-10-25. The firm's main businesses are the research and development, manufacturing and sales of nutritional products made from traditional Chinese medicine and animal extracts. The firm's main products include spore powder, cordyceps mycelium products, donkey-hide gelatin solution products, vitamins and dietary supplement products, American ginseng products and other nutrition products. The firm also engages in e-commerce and auto sales through the platforms Happy Buy and Taochejun.

Industry: Services-Computer Processing & Data Preparation Peers: China Health Industries Holdings, Inc. SHINECO, INC.